New data from the ongoing Open-Label Phase III Extension Study of PXT3003, the PLEO-CMT-FU trial,…
New Data from the Open-Label PLEO-CMT-FU Trial Shows Sustained Benefit with PXT3003 in Patients with…
SOM Biotech signs licensing agreement with the University of Minnesota Barcelona, Spain, 16 May 2022….
This credit facility is intended to support the progress and expansion of Inventiva’s pipeline The…
Analysis of primary study endpoint was completed with 7 patients showing a measurable residual disease…
Press Release Nicox Announces a New Governance Structure New governance structure with a separation of…
Saint-Herblain (France), May 16, 2022 – Valneva SE, a specialty vaccine company, today announced that…
GENEVA, Switzerland May 16, 2022 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company…
Saint Herblain (France), May 16, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a…
— The FDA has accepted an IND application supporting clinical development of ANG-3070 in IPF…
Running across clouds or on-prem, Kubecost provides the spend visibility and allocation necessary to significantly…
TOKYO, May 16, 2022 – (JCN Newswire) – Fujitsu today revealed its outlook for the…
TOKYO, May 16, 2022 – (JCN Newswire) – Mitsubishi Shipbuilding, a part of Mitsubishi Heavy…
HONG KONG, May 16, 2022 – (ACN Newswire) – CITIC Telecom International CPC Limited (“CITIC…
LONDON–(BUSINESS WIRE)–#BusinessServices–H.I.G. Capital (“H.I.G.”), a leading global alternative asset investment firm with over $49 billion…
PARIS–(BUSINESS WIRE)–GrAI Matter Labs, a pioneer of brain-inspired ultra-low latency computing, announced today that it…
HONG KONG, May 16, 2022 – (ACN Newswire) – Tam Jai International Co. Limited (“TJI”…
BANGKOK, May 16, 2022 – (ACN Newswire) – Kerry Express (Thailand) PCL (SET: KEX) Chief…
WALTHAM, Mass. and SHANGHAI, China, May 15, 2022 (GLOBE NEWSWIRE) — Zenas BioPharma, a global…
Orphazyme A/S in restructuringCompany announcementNo. 24/2022Inside informationwww.orphazyme.comCompany Registration No. 32266355 KemPharm to acquire Orphazyme…